Related Experiment Video
Updated: Aug 7, 2025

Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells
Published on: March 28, 2025
Fumarate induces vesicular release of mtDNA to drive innate immunity
Vincent Zecchini1, Vincent Paupe2, Irene Herranz-Montoya1,3
1Medical Research Council Cancer Unit, University of Cambridge, Cambridge, UK.
Abstract:
Mutations in fumarate hydratase (FH) cause hereditary leiomyomatosis and renal cell carcinoma1. Loss of FH in the kidney elicits several oncogenic signalling cascades through the accumulation of the oncometabolite fumarate2. However, although the long-term consequences of FH loss have been described, the acute response has not so far been investigated. Here we generated an inducible mouse model to study the chronology of FH loss in the kidney. We show that loss of FH leads to early alterations of mitochondrial morphology and the release of mitochondrial DNA (mtDNA) into the cytosol, where it triggers the activation of the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING)-TANK-binding kinase 1 (TBK1) pathway and stimulates an inflammatory response that is also partially dependent on retinoic-acid-inducible gene I (RIG-I). Mechanistically, we show that this phenotype is mediated by fumarate and occurs selectively through mitochondrial-derived vesicles in a manner that depends on sorting nexin 9 (SNX9). These results reveal that increased levels of intracellular fumarate induce a remodelling of the mitochondrial network and the generation of mitochondrial-derived vesicles, which allows the release of mtDNAin the cytosol and subsequent activation of the innate immune response.
Insights
Loss of fumarate hydratase (FH) triggers early kidney cell inflammation by releasing mitochondrial DNA. This innate immune response is mediated by fumarate accumulation and mitochondrial changes.
Area of Science:
- Cell Biology
- Molecular Biology
- Oncology
Background:
- Mutations in fumarate hydratase (FH) are linked to hereditary leiomyomatosis and renal cell carcinoma.
- FH loss in kidneys causes oncogenic signaling via fumarate accumulation, but the acute response remains unclear.
Purpose of the Study:
- To investigate the acute cellular response to fumarate hydratase loss in the kidney.
- To elucidate the molecular mechanisms underlying the early stages of FH-deficient renal cell carcinoma development.
Main Methods:
- Generation of an inducible mouse model for studying FH loss chronology in the kidney.
- Analysis of mitochondrial morphology, mitochondrial DNA release, and innate immune pathway activation (cGAS-STING-TBK1, RIG-I).
- Investigation of fumarate's role and the involvement of mitochondrial-derived vesicles and sorting nexin 9 (SNX9).
Main Results:
- FH loss rapidly alters mitochondrial morphology and releases mitochondrial DNA (mtDNA) into the cytosol.
- Cytosolic mtDNA activates the cGAS-STING-TBK1 and RIG-I innate immune pathways, inducing inflammation.
- Fumarate mediates this response through SNX9-dependent mitochondrial-derived vesicles.
Conclusions:
- Acute FH loss triggers an innate immune response in kidney cells via fumarate-induced mtDNA release.
- This study reveals a novel mechanism linking metabolic dysfunction to immune activation in renal cell carcinoma pathogenesis.
- Targeting fumarate accumulation or mitochondrial dynamics may offer therapeutic strategies for FH-related cancers.
More Related Videos
Related Concept Videos
Animal Mitochondrial Genetics
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
The Inner Mitochondrial Membrane
Mitochondrial Membranes

